Saudi Pharmaceutical Journal
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.3 | Q2 | 73.6% | 0.762 | Q2 | 75.7% |
| 2024 | 3.4 | Q2 | 68.3% | 0.677 | Q2 | 72.5% |
| 2023 | 3.0 | Q2 | 62.5% | 0.598 | Q2 | 70.8% |
| 2022 | 4.1 | Q2 | 72.5% | 0.629 | Q2 | 73.5% |
| 2021 | 4.6 | Q2 | 74.9% | 0.613 | Q2 | 73.5% |
| 2020 | — | — | 0.706 | Q2 | 76.4% | |
| 2019 | — | — | 0.700 | Q1 | 76.9% | |
| 2018 | — | — | 0.670 | Q1 | 73.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1319-0164
country
CHcoverage
1996-2026